drugset / Trial / NCT00358722

An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate

NCT00358722

Phase 2 Terminated 44 enrolled Ineos Healthcare Limited
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Fermagate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb. The purpose of this study it to look at the safety of fermagate over longer periods of time.

Timeline

Start
2006-07
Primary completion
2008-05
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Fermagate Unknown 500 mg